Close

Amgen (AMGN) PT Raised to $272 at Oppenheimer

June 1, 2021 3:29 PM EDT Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $272.00 (from $270.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login